On February 3, 2023, the Department of Justice Antitrust Division (DOJ) announced the withdrawal of three policy statements that have long guided the information exchanges as well as the related enforcement in the healthcare...more
5/3/2023
/ Antitrust Division ,
Antitrust Provisions ,
Competition ,
Department of Justice (DOJ) ,
Enforcement Actions ,
Families First Coronavirus Response Act (FFCRA) ,
Federal Trade Commission (FTC) ,
Healthcare ,
Joint Venture ,
Medicaid ,
Mergers ,
No Surprises Act (NSA) ,
Price Transparency ,
Public Health Emergency ,
Rulemaking Process ,
Transparency